Promimic AB (publ) (PRO.ST)
SEK 25.8
(-1.15%)
SEK 25.8
(-1.15%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | - SEK | 0.0% |
| 2022 | - SEK | -100.0% |
| 2021 | 833 Thousand SEK | 33.28% |
| 2020 | 625 Thousand SEK | -24.97% |
| 2019 | 833 Thousand SEK | -81.16% |
| 2018 | 4.42 Million SEK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | - SEK | 0.0% |
| 2024 Q1 | - SEK | 0.0% |
| 2023 Q2 | - SEK | 0.0% |
| 2023 FY | - SEK | 0.0% |
| 2023 Q4 | - SEK | 0.0% |
| 2023 Q3 | - SEK | 0.0% |
| 2023 Q1 | - SEK | 0.0% |
| 2022 Q2 | 3.19 Million SEK | -14.1% |
| 2022 Q4 | - SEK | 0.0% |
| 2022 Q3 | - SEK | -100.0% |
| 2022 FY | - SEK | -100.0% |
| 2022 Q1 | 3.71 Million SEK | 346.1% |
| 2021 Q4 | 833 Thousand SEK | -52.04% |
| 2021 Q3 | 1.73 Million SEK | -10.69% |
| 2021 FY | 833 Thousand SEK | 33.28% |
| 2021 Q2 | 1.94 Million SEK | -17.62% |
| 2021 Q1 | 2.36 Million SEK | 0.0% |
| 2020 FY | 625 Thousand SEK | -24.97% |
| 2019 FY | 833 Thousand SEK | -81.16% |
| 2018 FY | 4.42 Million SEK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acarix AB (publ) | - SEK | NaN% |
| ADDvise Group AB (publ) | 1.61 Billion SEK | 100.0% |
| ADDvise Group AB (publ) | 1.61 Billion SEK | 100.0% |
| Arcoma AB | 3.87 Million SEK | 100.0% |
| Bactiguard Holding AB (publ) | 233.09 Million SEK | 100.0% |
| BICO Group AB (publ) | 1.85 Billion SEK | 100.0% |
| Boule Diagnostics AB (publ) | 166.1 Million SEK | 100.0% |
| CellaVision AB (publ) | 64.7 Million SEK | 100.0% |
| Clinical Laserthermia Systems AB (publ) | 454 Thousand SEK | 100.0% |
| Chordate Medical Holding AB (publ) | - SEK | NaN% |
| C-Rad AB (publ) | 1.8 Million SEK | 100.0% |
| Duearity AB (publ) | 10.58 Million SEK | 100.0% |
| Dignitana AB (publ) | 19.1 Million SEK | 100.0% |
| Episurf Medical AB (publ) | 5.2 Million SEK | 100.0% |
| Getinge AB (publ) | 8.07 Billion SEK | 100.0% |
| Scandinavian Real Heart AB (Publ) | 8.24 Million SEK | 100.0% |
| Iconovo AB (publ) | 7.72 Million SEK | 100.0% |
| Integrum AB (publ) | 6.42 Million SEK | 100.0% |
| Luxbright AB (publ) | 206.02 Thousand SEK | 100.0% |
| Mentice AB (publ) | 9.55 Million SEK | 100.0% |
| OssDsign AB (publ) | 3.15 Million SEK | 100.0% |
| Paxman AB (publ) | 13.57 Million SEK | 100.0% |
| Qlife Holding AB (publ) | 20.73 Million SEK | 100.0% |
| SciBase Holding AB (publ) | 6.79 Million SEK | 100.0% |
| ScandiDos AB (publ) | - SEK | NaN% |
| Sectra AB (publ) | 31.78 Million SEK | 100.0% |
| Sedana Medical AB (publ) | 4.3 Million SEK | 100.0% |
| Senzime AB (publ) | 11.46 Million SEK | 100.0% |
| SpectraCure AB (publ) | 6.71 Million SEK | 100.0% |
| Stille AB | 62.94 Million SEK | 100.0% |
| Vitrolife AB (publ) | 2.08 Billion SEK | 100.0% |
| Xvivo Perfusion AB (publ) | 31.43 Million SEK | 100.0% |